Abbott’s revenue drops due to drop in Covid-related sales

Abbott Laboratories

reported fourth-quarter adjusted earnings that beat Wall Street estimates but sales fell 12% from a year earlier due to what the company called an “expected decline compared to the previous year.” same period last year for sales related to Covid-19 testing.”

Shares of Abbott (ticker: ABT) were down 1.8% in premarket trading.


News7F: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, the World everyday world. Hot news, images, video clips that are updated quickly and reliably

Related Articles

Back to top button